CannaInsider posted a very timely interview today with PharmaCielo CEO Dr. Patricio Stocker. Just last week, the New York Times profiled the company, suggesting it was set to benefit financially as Colombia legalizes cannabis production for medicinal purposes. The Canadian company, with operations in Colombia, is focused on creating oils and extracts in a vertically integrated process where it grows its supply in open air greenhouses, taking advantage of 12-hour constant sunlight and natural water resources.
Stocker explained the company’s focus on quality and low cost of production as well as its commitment to sustainable processes. PharmaCielo has received its extraction license and is close to earning its cultivation license. It will be seeking an export license as well, which will enable it to supply countries like Canada, Australia, South Africa and European countries, but the domestic market will be the first market and then other Latin American countries, particularly Brazil.
Key Takeaways:
[1:10] – Dr. Stocker talks about his background
[2:19] – What is PharmaCielo
[5:10] – The government regulatory system in Colombia
[6:58] – The growing environment in Colombia
[11:14] – How the political & crime situation has improved in Colombia
[15:55] – Leveraging Colombians experience with flowers and coffee
[20:16] – What countries does PharmaCielo export their product to
[22:37] – Where the cannabis market is headed the next five years
[26:30] – Environmental standards that PharmaCielo adhere to
[30:47] – Dr. Stocker answers some personal development questions
[38:40] – Contact details for PharmaCielo
Listen to the interview or read the transcript “PharmaCielo is Growing Cannabis At The Equator to Export to The World”: http://www.cannainsider.com/pharmacielo/
